Bosh sahifaGUD • TSE
add
Knight Therapeutics Inc
Yopilish kursi
5,75 $
Kunlik diapazon
5,74 $ - 5,78 $
Yillik diapazon
5,09 $ - 6,23 $
Bozor kapitalizatsiyasi
575,28 mln CAD
Oʻrtacha hajm
62,69 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
TSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CAD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 92,26 mln | 13,21% |
Joriy xarajat | 41,81 mln | 6,53% |
Sof foyda | 85,00 ming | -99,11% |
Sof foyda marjasi | 0,09 | -99,23% |
Har bir ulushga tushum | — | — |
EBITDA | 16,59 mln | 13,43% |
Amaldagi soliq stavkasi | 86,02% | — |
Balans
Jami aktivlari
Jami passivlari
| (CAD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 172,32 mln | 7,75% |
Jami aktivlari | 962,29 mln | -4,83% |
Jami passivlari | 188,38 mln | -4,12% |
Umumiy kapital | 773,91 mln | — |
Tarqatilgan aksiyalar | 100,80 mln | — |
Narxi/balansdagi bahosi | 0,75 | — |
Aktivlardan daromad | 0,84% | — |
Kapitaldan daromad | 0,97% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CAD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 85,00 ming | -99,11% |
Operatsiyalardan naqd pul | 5,02 mln | -66,93% |
Sarmoyadan naqd pul | 11,53 mln | -67,76% |
Moliyadan naqd pul | -3,93 mln | 65,06% |
Naqd pulning sof oʻzgarishi | 12,95 mln | -67,28% |
Boʻsh pul | 1,02 mln | 121,60% |
Haqida
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
Tashkil etilgan
2014
Bosh ofis
Sayt
Xodimlar soni
725
